Skip to main content
Back to timeline
Venture CapitalSource publication:

MegaRobo raises nearly US$200 million to wire AI agents into real laboratory loops

Synopsis

MegaRobo announced it has raised nearly US$200 million in a new financing round joined by Oman Investment Authority, with existing investors Asia Investment Capital, Granite Asia and Sinovation Ventures continuing to back the company and CMB International joining as a new investor. The proceeds will fund core technology, global expansion of its AI for Science business, and infrastructure that lets AI operate in increasingly complex physical environments. The company describes its One Intelligence Stack as a reusable foundation combining models and agents, data, workflows, software, scientific instruments, robotics, automation and real-world feedback, with scientific discovery as the first proving ground.

AI-generated editorial illustration: MegaRobo Raises Nearly US$200 Million in New Funding to Build Intelligence Infrastructure for the Physical World

Interpretation

MegaRobo raised nearly US$200 million in a new financing round, with the proceeds directed at core technology, global expansion of its AI for Science business, and infrastructure for AI to operate in more complex physical environments. The company had previously raised approximately US$600 million across multiple rounds, including a nearly US$300 million Series C co-led by Goldman Sachs Alternatives, Asia Investment Capital and Granite Asia, with participation from Pavilion Capital. Oman Investment Authority joined the round, existing investors Asia Investment Capital, Granite Asia and Sinovation Ventures continued to back the company, and CMB International participated as a new investor.

The architecture links intelligence to execution in a think, design, execute, observe, learn chain, so AI does more than analyze information: it can design experiments, run them in real laboratories, observe outcomes and update on what happens. The first generation of AI learned mainly from digital information such as text, images, video and code, whereas scientific discovery depends on a continuing loop of reasoning, design, physical experimentation, observation and learning. The company says it has delivered products and technologies to more than 500 customers, including global pharmaceutical companies, drug discovery organizations, biotechnology companies and research institutions, supporting stages from early research and target and mechanism discovery to drug screening and candidate optimization.

Megalaxy Lab makes real-world experimentation more programmable: researchers and AI agents can configure experiments, route them to automated laboratory systems, track execution, and receive structured, machine-readable results that feed the next cycle of scientific reasoning. Experimental capacity had been organized mainly as individual projects; the company describes it as increasingly standardized, automated and callable on demand. Megalaxy Lab has served more than 200 customers, and with partners including Tencent Cloud and Twist Bioscience the company launched Poreva Open, a global AI protein design challenge in which Megalaxy Lab will provide wet-lab validation for more than 10,000 protein design sequences.

Perspective

The report is limited to MegaRobo's financing announcement and its descriptions of One Intelligence Stack, Megalaxy Lab and Poreva Open; customer counts, validation sequence scale and cumulative funding are company statements, with no experimental results or performance comparisons given.

The announcement does not state the round's specific terms, nor Poreva Open's launch timing, review process or validation results; it describes One Intelligence Stack's role in scientific settings only in positioning terms, without accompanying experimental results.